Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Poziotinib for Advanced Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Houston, Texas
This trial is studying how well poziotinib works to treat patients with non-small lung cancer that has an EGFR or HER2 exon 20 mutation and is stage IV or has come back (recurrent). Poziotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.